Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
Filippo Ceccato, Laura Lizzul, Giacomo Voltan, et al.
Pituitary (2021) Vol. 24, Iss. 6, pp. 914-921
Open Access | Times Cited: 11

Showing 11 citing articles:

Treatment of Prolactinoma
Warrick J. Inder, Christina Jang
Medicina (2022) Vol. 58, Iss. 8, pp. 1095-1095
Open Access | Times Cited: 34
Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment
Łukasz Działach, Joanna Sobolewska, Zuzanna Żak, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Long-term Follow-up of 84 Patients With Giant Prolactinomas—A Swedish Nationwide Study
Christos Himonakos, Pia Burman, Henrik Borg, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 12, pp. e1506-e1514
Open Access | Times Cited: 8
Prolactinomas Resistant to Dopamine Agonists: Pathophysiology and Treatment
Ilan Shimon
Archives of Medical Research (2023) Vol. 54, Iss. 8, pp. 102883-102883
Closed Access | Times Cited: 7
The Role of Aromatase Inhibitors in Male Prolactinoma
Amit Akirov, Yaron Rudman
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1437-1437
Open Access | Times Cited: 6
Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas
Giacomo Voltan, Pierluigi Mazzeo, Daniela Regazzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9920-9920
Open Access | Times Cited: 4
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways
Simona Serioli, Ludovico Agostini, Alberto Pietrantoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15719-15719
Open Access | Times Cited: 4
Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma
Ticiana Paes, Jacobo Buelvas Mebarak, John C Magnotto, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 1
Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes
Liza Das, Ashutosh Rai, Pravin Salunke, et al.
Journal of the Endocrine Society (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 9
Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review
Diana Zúñiga, Matheo Augusto Morandi Stumpf, Anna Louise Stellfeld Monteiro, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 5, pp. 1295-1303
Closed Access | Times Cited: 2
Recent advances in understanding and managing pituitary adenomas
M. Markou, Aikaterini Lavrentaki, Georgia Ntali
Faculty Reviews (2023) Vol. 12
Open Access | Times Cited: 1
Page 1

Scroll to top